Neuropeptide Y expression in cutaneous melanoma

Area of Science:

• Oncology
• Dermatology
• Neuroendocrinology

Background:

• Neuropeptide Y (NPY) is a neuromodulator with diverse physiological roles.
• NPY receptors are found in various cancers, including melanoma.
• α-melanocyte-stimulating hormone (MSH) is implicated in melanoma pathogenesis.

Purpose of the Study:

• To investigate Neuropeptide Y (NPY) expression in cutaneous melanoma.
• To correlate NPY levels with clinical and histological features of melanoma.
• To examine the relationship between NPY and α-MSH in melanoma.

Main Methods:

• Observational study utilizing immunohistochemistry.
• Analysis of tissue samples from primary cutaneous melanomas, melanoma metastases, and melanocytic nevi.
• Quantification of NPY and α-MSH expression.

Main Results:

• NPY and α-MSH levels were significantly higher in melanomas compared to nevi (P < .001).
• Nodular melanomas exhibited the highest NPY expression; lentigo maligna showed none.
• NPY expression correlated positively with vertical growth and metastasis presence (P < .05).
• Melanoma metastases were negative for both NPY and α-MSH.

Conclusions:

• Neuropeptide Y (NPY) is significantly expressed in cutaneous melanomas, particularly nodular types.
• NPY expression is associated with melanoma invasiveness, independent of proliferative markers.
• The absence of NPY and α-MSH in metastases suggests a distinct biological behavior.